An Exploratory Assessment of Risk and Resilience in Pharmaceutical Supply Chains

4Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.
Get full text

Abstract

With medicines shortages becoming an increasingly prevalent issue, it is necessary to carry out an assessment of the resilience of pharmaceutical supply chains, to determine where vulnerabilities exist which may be contributing to the shortages problem. This chapter describes an initial exploratory assessment of supply chain resilience in the downstream section of pharmaceutical supply chains. Using a previously validated approach (the Supply Chain Risk Assessment Method—SCRAMTM), survey data was collected from a number of supply chain managers dedicated to pharmaceutical sector. The findings suggest a number of areas in which supply chain capabilities require improvement in order to develop more resilience supply chains, particularly flexibility in sourcing; flexibility in order fulfilment; visibility and collaboration.

Cite

CITATION STYLE

APA

Ward, R., & Hargaden, V. (2019). An Exploratory Assessment of Risk and Resilience in Pharmaceutical Supply Chains. In Lecture Notes in Logistics (pp. 111–123). Springer Science and Business Media B.V. https://doi.org/10.1007/978-3-030-15398-4_7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free